The porphyrias

Emergency Medicine Clinics of North America

Volumn 23, Issue 3 SPEC. ISS., 2005, Pages 885-899

  Dombeck, Teague A ^a   Satonik, Robert C ^a  

^a Synergy Medical Education Alliance   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; ACICLOVIR; ADRENALIN; ALLOPURINOL; AMILORIDE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMIDE; BUMETANIDE; BUPRENORPHINE; CHLOROQUINE; CHLORPROMAZINE; CIMETIDINE; CIPROFLOXACIN; CORTICOSTEROID; DEFEROXAMINE; DIGITALIS; ERYTHROMYCIN; FUROSEMIDE; GENTAMICIN; INDOMETACIN; INSULIN; METFORMIN; METOCLOPRAMIDE; PARACETAMOL; PENICILLIN G; PETHIDINE; PROPOFOL; UNINDEXED DRUG;

ACUTE INTERMITTENT PORPHYRIA; ADULT; BIOSYNTHESIS; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; EMERGENCY WARD; ENZYME DEFECT; FEMALE; HUMAN; INFORMATION PROCESSING; MEDICAL INFORMATION; MEDICAL LITERATURE; PATHOPHYSIOLOGY; PORPHYRIA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; REVIEW;

EID: 20744449834     PISSN: 07338627     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.emc.2005.03.014     Document Type: Review

References (32)

1. G.H. Elder Porphyria cutanea tarda Semin Liver Dis 18 1 1998 67 75
2. S. Sassa, and A. Kappas The porphyrias 9 2003 1 9 [Available from WebMD Inc., Accessed May 1, 2004]
3. H. Werman The porphyrias Emerg Clin North Am 7 4 1989 927 942
4. H.L. Bonkowsky, and W. Schady Neurologic manifestations of acute porphyria Semin Liver Dis 2 1982 108 124
5. B.C. Shanley, A.C. Neethling, and V.A. Percy Neurochemical aspects of porphyria: studies on the possible neurotoxicity of delta-aminolevulinic acid S Afr J Med 49 1975 576 580
6. B.C. Shanley, V.A. Percy, and A.C. Neethling Neurochemistry to acute porphyria: experimental studies on delta-aminolevulinic acid and porphobilinogen M. Doss Porphyrins in human disease 1976 S Karger Basel
7. J.D. Spikes Porphyrins and related compounds as photodynamic sensitizers Ann N Y Acad Sci 244 1975 496 508
8. A. Kappas, S. Sassa, and R.A. Galbraith The porphyrias C.R. Scriver A.L. Beaudet W.S. Sly The metabolic and molecular basis of inherited disease 1995 McGraw-Hill New York 2103 2159
9. M.B. Poh-Fitzpatrick Pathogenesis and treatment of photocutaneous manifestations of the porphyrins Semin Liver Dis 2 1982 164 176
10. P. Gilbertini, E. Rocchi, and A. Cassanelli Advances in the treatment of porphyria cutanea tarda: effectiveness of slow subcutaneous desferrioxamine infusion Liver 4 1984 280 284
11. A. Goldberg, and C. Rimingron Diseases of porphyrin metabolism 1962 Charles C. Thomas Springfield (IL)
12. C. Andersson, E. Innala, and T. Backstrom Acute intermittent porphyria in women: clinical expression, use and experience of exogenous sex hormones: a population-based study in northern Sweden J Intern Med 254 2003 176 183
13. T.S. Zimmerman, J.M. McMillin, and C.J. Watson Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones Arch Intern Med 118 1966 229 240
14. F.H. Welland, E.S. Hellman, and A. Collins Factors affecting the excretion of porphyrin precursors by a patient with acute intermittent porphyria: II. The effect of ethinyl estradiol Metabolism 13 1964 251 258
15. G.H. Elder, R.T. Hift, and P.N. Neissner The acute porphyrias Lancet 349 1997 82 83
16. P.B. Disler, and L. Eales The acute attack of porphyria S Afr Med J 61 1982 82 83
17. H.L. Bonkowsky, P.R. Sinclair, and S. Emery Seizure management in acute hepatic porhyria: risks of valproate and clonazepam Neurology 30 1980 588 592
18. A.W. Larson, W.R. Wasserstrom, and B.F. Felsher Post-traumatic epilepsy and acute intermittent porphyria: effects of phenytoin, carbamazepine, and clonazepam Neurology 28 1978 824 828
19. C.R. Magnessen, J.M. Doherty, and R.A. Hess Grand mal seizures and acute intermittent porphyria Neurology 25 1975 1121 1125
20. S. Sassa Diagnosis and therapy of acute intermittent porphyria Blood Rev 10 1966 53 58
21. P. Mustajoki, R. Tenhunen, and C. Pierach Heme in the treatment of porphyrias and hematological disorders Semin Hematol 26 1989 1 9
22. C.A. Pierach Hematin therapy for the porphyric attack Semin Liver Dis 2 1982 125 131
23. J.M. Lamon, B.C. Frykholm, and R.A. Hess Hematin therapy for acute porphyria Medicine 58 1979 252 269
24. B.A. DeLeo, M.B. Poh-Fitzpatrick, and M. Matthews-Roth Erythropoietic protoporphyria, 10 years experience Am J Med 60 1976 8 22
25. M.B. Poh-Fitzpatrick Erythropoietic protoporphyria Int J Dermatol 17 1978 359 369
26. L. Eales, R.S. Day, and G.H. Blekkenhorst The clinical and biochemical features of variegate porphyria: an analysis of 300 cases studies at Groote Schuur Hospital, Cape Town Int J Biochem 12 1980 837 853
27. P.N. Meissner, T.A. Dailey, and R.J. Hift A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria Nature 13 1996 95 97
28. G. Dean The porphyrias: a study of inheritance and environment 1971 Pitman Medical London
29. J.E. Muhlbauer, M.A. Pathak, and P.V. Tishler Variegate porphyria in New England JAMA 247 1982 3095 3120
30. G. Dunea Vampires BMJ 318 717 1999 135A
31. F.A. Harada, T.A. Shwayder, and R.J. Desnick Treatment of severe congenital erythropoietic porphyria by bone marrow transplantation J Am Acad Dermatol 45 2001 274 282
32. J.L. Granick, S. Sassa, and A. Kappas Some biochemical and clinical aspects of lead intoxication O. Bodansky A.L. Latner Advances in clinical chemistry 1978 Academic Press New York 287